First Time Loading...

Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 15.9 AUD 5.02% Market Closed
Updated: Jun 1, 2024

Clinuvel Pharmaceuticals Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clinuvel Pharmaceuticals Ltd
Current Portion of Long-Term Debt Peer Comparison

Comparables:
IMM
MSB
CSL
TLX
PYC

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Current Portion of Long-Term Debt
AU$355.8k
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Current Portion of Long-Term Debt
AU$210.1k
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Current Portion of Long-Term Debt
$11.4m
CAGR 3-Years
-36%
CAGR 5-Years
30%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Current Portion of Long-Term Debt
$1.4B
CAGR 3-Years
47%
CAGR 5-Years
21%
CAGR 10-Years
70%
Telix Pharmaceuticals Ltd
ASX:TLX
Current Portion of Long-Term Debt
AU$1.6m
CAGR 3-Years
27%
CAGR 5-Years
7%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Current Portion of Long-Term Debt
AU$324.4k
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
355.8k AUD

Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt amounts to 355.8k AUD.

What is Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
14%

Over the last year, the Current Portion of Long-Term Debt growth was 10%. The average annual Current Portion of Long-Term Debt growth rates for Clinuvel Pharmaceuticals Ltd have been 14% over the past three years .